SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041198
Filing Date
2023-11-14
Accepted
2023-11-14 16:39:58
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1816956
2 ex31-1.htm EX-31.1 11133
3 ex31-2.htm EX-31.2 7669
4 ex32-1.htm EX-32.1 4510
5 ex32-2.htm EX-32.2 4730
  Complete submission text file 0001493152-23-041198.txt   8888566

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sigy-20230930.xsd EX-101.SCH 39948
7 XBRL CALCULATION FILE sigy-20230930_cal.xml EX-101.CAL 49745
8 XBRL DEFINITION FILE sigy-20230930_def.xml EX-101.DEF 155446
9 XBRL LABEL FILE sigy-20230930_lab.xml EX-101.LAB 312757
10 XBRL PRESENTATION FILE sigy-20230930_pre.xml EX-101.PRE 267991
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1912284
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 231407267
SIC: 3841 Surgical & Medical Instruments & Apparatus